Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-26T03:37:38.711Z Has data issue: false hasContentIssue false
  • English
  • Français

Schizophrenia trials: past, present and future

Published online by Cambridge University Press:  11 October 2011

Clive E. Adams
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Epidemiology and Psychiatric Sciences , Volume 11 , Issue 3 , September 2002 , pp. 144 - 151
Copyright
Copyright © Cambridge University Press 2002

References

REFERENCES

Adams, C. & Gelder, M. (1994). The case for establishing a register of randomised controlled trials of mental health care. A widely accessible register will minimise bias for those reviewing care. British Journal of Psychiatry 164, 433–436.CrossRefGoogle ScholarPubMed
Adams, C. & Gilbody, S. (2001). Nobody ever expects the Spanish Inquisition (Python, 1991). Psychological Bulletin 25, 291–292.Google Scholar
Ahmed, I., Soares, K., Seifas, R. & Adams, C. (1998). Randomized controlled trials in Archives of General Psychiatry (1959-1995): a prevalence study. Archives of General Psychiatry 55, 754–755.CrossRefGoogle ScholarPubMed
Bowen, J. & Barnes, T.R.E. (1994). The clinical characteristics of schizophrenic patients consenting or not consenting to a placebo controlled trial of antipsychotic medication. Human Psychophannacology 9, 423–433.CrossRefGoogle Scholar
Britton, A., McKee, M., Black, N., McPherson, K., Sanderson, C. & Bain, C. (1999). Threats to applicability of randomised trials: exclusions and selective participation. Journal of Health Service Research Policy 4, 112–121.CrossRefGoogle ScholarPubMed
Chalmers, I. (1986). A register of controlled trials in perinatal medicine. WHO Chronicle 40, 61–65.Google ScholarPubMed
Chalmers, I., Hetherington, J., Newdick, M, Mutch, L., Grant, A., Enkin, M., Enkin, E. & Dickersin, K. (1986). The Oxford Database of Perinatal Trials: developing a register of published reports of controlled trials. Controlled Clinical Trials 7, 306–324.CrossRefGoogle ScholarPubMed
Chalmers, I., Dickersin, K. & Chalmers, T. (1992). Getting to grips with Archie Cochrane's agenda. British Medical Journal 305, 786–788.CrossRefGoogle ScholarPubMed
Cheng, K., Smyth, R., Motley, J., O'Hea, U. & Ashby, D. (2000). Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention. Pediatric pulmonology 29, 1–7.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Clark, M., Dubowski, K. & Colmore, J. (1970). The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients. Clinical Pharmacology and Therapeutics 16, 883–889.CrossRefGoogle Scholar
Cochrane Collaboration Schizophrenia Review Group (1994). Schizophrenia and the Cochrane Collaboration. Schizophrenia Research 13, 185–188.CrossRefGoogle Scholar
Collaborative Eclampsia Trial Group (1995). Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345, 1455–1463.CrossRefGoogle Scholar
Crowther, R., Marshall, M., Bond, G. & Huxley, P. (2001). Vocational rehabilitation for people with severe mental illness. Cochrane Database Systematic Reviews CDO03080.CrossRefGoogle Scholar
Dickersin, K., Hewitt, P., Mutch, L., Chalmers, I. & Chalmers, T. (1985). Perusing the literature: comparison of MEDLINE searching with a perinatal trials database. Controlled Clinical Trials 6, 306–317.CrossRefGoogle ScholarPubMed
Doll, R. (1998). Controlled trials: the 1948 watershed. British Medical Journal 317, 1217–1220.CrossRefGoogle ScholarPubMed
Duggan, L., Fenton, M., Dardennes, R.M., El-Dosoky, A. & Indran, S. (2001). Olanzapine for schizophrenia (Cochrane Review). Cochrane Database Systematic Reviews 2.Google Scholar
Easterbrook, P., Berlin, J., Gopalan, R. & Matthews, D. (1991). Publication bias in clinical research. Lancet 337, 867–872.CrossRefGoogle ScholarPubMed
Egger, M., Zellweger-Zahner, T., Schneider, M., Junker, C., Lengeler, C. & Antes, G. (1997). Language bias in randomised controlled trials published in English and German. Lancet 350, 326–329.CrossRefGoogle ScholarPubMed
Fahey, T., Hyde, C., Milne, R. & Thorogood, M. (1995). The type and quality of randomized controlled trials (RCTs) published in UK public health journals. Journal of Public Health Medicine 17, 469–474.Google ScholarPubMed
Freeman, H. (1958). The tranquilising drugs. In Schizophrenia: a Review of the Syndrome (ed. Bellak, L.). Logos Press: New York.Google Scholar
Galson, S., Kweder, S., Houn, F., Raczkowski, V., Honig, P., Hirshfield, S., Kieffer, L., McGuinn, W., Rothmann, M., Timmer, W., Malozowski, S., Christensen, J., Walker, A. & Horton, R. (2001). The FDA and the Lancet: an exchange. Lancet 358, 415–418.CrossRefGoogle ScholarPubMed
Gilbody, S., Wahlbeck, K. & Adams, C. (2002). Randomized controlled trials in schizophrenia: a critical perspective on the literature. Acta Psychiatrica Scandinavica 105, 243–251.CrossRefGoogle ScholarPubMed
Gotzsche, P. (1989). Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Controlled Clinical Trials 10, 31–56.CrossRefGoogle ScholarPubMed
Horton, R. (2001). Lotronex and the FDA: a fatal erosion of integrity. Lancet 357, 1544–1545.CrossRefGoogle ScholarPubMed
Hotopf, M., Churchill, R. & Lewis, G. (1999). Pragmatic randomised controlled trials in psychiatry. British Journal of Psychiatry 175, 217–223.CrossRefGoogle ScholarPubMed
Huf, G., Coutinho, E.S.F. & Adams, C.E. (2002). TREC III. The protocol and progress of TREC. Schizophrenia Research (Abstracts of the 11 th Biennial Winter Workshop on Schizophrenia) 53, 187.Google Scholar
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group (1995). ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345, 669–685.CrossRefGoogle Scholar
Jadad, A., Moore, R., Carroll, D., Jenkinson, C., Reynolds, D., Gavaghan, D. & McQuay, H. (1996). Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 17, 1–12.CrossRefGoogle ScholarPubMed
Jadad, A.R., Cook, D.J., Jones, A., Klassen, T.P., Tugwell, P., Moher, M. & Moher, D. (1998). Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. Journal of American Medical Association 280, 278–280.CrossRefGoogle ScholarPubMed
Joy, C.B., Lawrie, S. & Adams, C.E. (2001). Haloperidol versus placebo for schizophrenia (Cochrane Review). Cochrane Database of Systematic Reviews 2, Update Software.CrossRefGoogle Scholar
Kennedy, E., Song, F., Hunter, R., Clarke, A. & Gilbody, S. (2001). Risperidone versus typical antipsychotic medication for schizophrenia (Cohrane Review). Coclirane Database of Systematic Reviews 2, Update Software.Google Scholar
Lent, V. & Langenbach, A. (1996). A retrospective quality analysis of 102 randomized trials in four leading urological journals from 1984-1989. Urological Research 24, 119–22.CrossRefGoogle ScholarPubMed
Marshall, M. & Lockwood, A. (2000). Assertive community treatment for people with severe mental disorders (Cochrane Review). Cochrane Database of Systematic Reviews 2, CD001089, Update Software.Google Scholar
Marshall, M., Lockwood, A., Adams, C., Bradley, C., Joy, C. & Fenton, M. (2000a). Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia? British Journal of Psychiatry 176, 249–252.CrossRefGoogle Scholar
Marshall, M., Gray, A., Lockwood, A. & Green, R. (2000b). Case management for people with severe mental disorders (Cochrane Review). Cochrane Database of Systematic Reviews 2, CD000050, Update Software.Google Scholar
Medical Research Council Streptomycin in Tuberculosis Trials Committee (1948). Streptomycin treatment for pulmonary tuberculosis. British Medical Journal 2, 769–779.CrossRefGoogle Scholar
Moher, D., Pham, B., Jones, A., Cook, D., Jadad, A., Moher, M., Tugwell, P. & Klassen, T. (1998). Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352, 609–613.CrossRefGoogle ScholarPubMed
Moher, D., Schulz, K.F. & Airman, D.G. (2001). The CONSORT statement revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357, 1191–1194.CrossRefGoogle Scholar
Naylor, D. (1995). Grey zones of clinical practices: some limits to evidence based medicine. Lancet 345, 840–842.CrossRefGoogle ScholarPubMed
Nicolucci, A., Grilli, R., Alexanian, A., Apolone, G., Torn, V. & Liberati, A. (1989). Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. Journal of American Medical Association 262, 2101–2107.CrossRefGoogle ScholarPubMed
Roland, M. & Torgerson, D. (1998). What are pragmatic trials? British Medical Journal 316, 285.CrossRefGoogle ScholarPubMed
Schulz, K., Chalmers, I., Grimes, D. & Altman, D. (1994). Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. Journal of American Medical Association 272, 125–128.CrossRefGoogle ScholarPubMed
Schwartz, D. & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Diseases 20, 637–648.CrossRefGoogle ScholarPubMed
Sheldon, T.A. (1994). Please bypass the PORT. British Medical Journal 309, 142–143.CrossRefGoogle ScholarPubMed
Silagy, C. (1993). Developing a register of randomised controlled trials in primary care. British Medical Journal 306, 897–900.CrossRefGoogle ScholarPubMed
Silagy, C., Gray, S., Fowler, G. & Lancaster, T. (1996a). Development of a prospective register of smoking cessation trials. Controlled Clinical Trials 17, 235–41.CrossRefGoogle ScholarPubMed
Silagy, C., Gray, S., Fowler, G. & Lancaster, T. (1996b). Development of a prospective register of smoking cessation trials. Controlled Clinical Trials 17, 235–41.CrossRefGoogle ScholarPubMed
Simon, G., Wagner, E. & Vonkorff, M. (1995). Cost-effectiveness comparisons using “real world” randomized trials: the case of new anndepressant drugs. Journal of Clinical Epidemiology 48, 363–373.CrossRefGoogle ScholarPubMed
Simon, G.E., VonKorff, M., Heiligenstein, J.H., Revicki, D.A., Grothaus, L., Katon, W. & Wagner, E.H. (1996). Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. Journal of American Medical Association 275, 1897–902.CrossRefGoogle ScholarPubMed
Stem, J. & Simes, R. (1997). Publication bias: evidence of delayed publication in a cohort study of clinical research projects. British Medical Journal 315, 640–645.Google Scholar
Thornley, B. & Adams, C. (1998a). Content and quality of 2000 controlled trials in schizophrenia over 50 years. British Medical Journal 317, 1181–1184.CrossRefGoogle ScholarPubMed
Thornley, B. & Adams, C. (1998b). Content and quality of 2000 controlled trials in schizophrenia over 50 years. British Medical Journal 317, 1181–1184.CrossRefGoogle ScholarPubMed
Thornley, B., Adams, C.E. & Awad, G. (2001). Chlorpromazine versus placebo for schizophrenia (Cochrane Review). Cochrane Database of Systematic Reviews 2, Update Software.Google Scholar
Update Software Ltd (2002). Abstracts of Cochrane reviews.Google Scholar
Vandekerckhove, P., O'Donovan, P., Lilford, R. & Harada, T. (1993). Infertility treatment: from cookery to science. The epidemiology of randomised controlled trials. British Journal of Obstetrics and Gynaecology 100, 1005–1036.CrossRefGoogle ScholarPubMed
Wahlbeck, K., Adams, C. & Thomley, B. (2000). Much to improve: a survey of controlled Nordic schizophrenia trials. Nordic Journal of Psychiatry 54, 105–108.CrossRefGoogle Scholar
Wells, K. (1999). Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. American Jounxal of Psychiatry 156, 5–10.CrossRefGoogle ScholarPubMed
Whicher, E., Morrison, M. & Douglas-Hall, P. (2002). ‘As required’ medication regimens for seriously mentally ill people in hospital. Cochrane Database of Systematic Reviews 2, Update Software.CrossRefGoogle Scholar
WHO Scientific Group on Treatment of Psychiatric Disorders (1991). Evaluation of Methods for the Treatment of Mental Disorders. WHO: Geneva.Google Scholar